Services

BioCheck provides a variety of services including:

  • Custom Immunoassay Development
  • Antibody Purification and Conjugation
  • Contract Manufacturing and Assembly

    IMMUNOASSAY DEVELOPMENT

    BioCheck performs custom immunoassay development for the biopharmaceutical industry. With over 45 years of collective product development experience, BioCheck can quickly and economically deliver custom assays for any biomarkers.

    BioCheck has developed assays in the area of:

  • Cardiovascular Disease
  • Tumor Markers
  • Infectious Diseases
  • Reproductive and Fertility
  • Steroids
  • Metabolism
  • Diabetes

    BioCheck's clients trust our expertise and capabilities in immunoassay development, regarding us as an extension of their internal R&D department. BioCheck works closely with clients to bring new IVD products to market.

    The development process includes:

  • Feasibility Studies
  • Optimization
  • Performance Data Generation
  • Clinical Sample Testing for Kit Validation
  • Device Master Record
  • Design Transfer

    ANTIBODY PURIFICATION

    BioCheck provides monoclonal and polyclonal antibody purifications including:

  • DEAE column
  • Sephacryl Size Exclusion Column
  • Protein A column
  • Protein G column
  • Antigen Affinity Column

    ANTIBODY CONJUGATION

    BioCheck uses proprietary methods to prepare stable antibody-HRP conjugates, and antibody-biotin conjugates which are stable for 5+ years.

    MANUFACTURING AND ASSEMBLY

    BioCheck offers contract manufacturing under its cGMP and ISO 13485 certified facility. Contract manufacturing and assembly include:

  • Microtiter Plate Coating (3+ year stability and excellent reproducibility)
  • Lyophilization of Kit Components
  • Individual Reagent Manufacturing, Dispensing and Labeling
  • Immunoassay Kit Manufacturing, Assembly and Distribution

    CUSTOM RECOMBINANT MONOCLONAL ANTIBODY DEVELOPMENT

    Rabbit, Goat & Mouse Recombinant monoclonal antibody services

  • Proprietary single B cell IgG gene cloning technology
  • Antibody gene cloning from hybridoma cell lines
  • Recombinant small scale and bulk antibody production

    ANTIBODY IHC SCREENING

    Cell and tissue based IHC antibody assay screening platform

  • large collection of FFPE cell blocks and the access to 140,000 well documented tissues for high quality IHC antibody development

    UltraMAB antibody specificity evaluation platform

  • The only available technology platform to evaluate antibody specificity at the genome-wide level

    CONTACT INFORMATION

    If interested, please contact BioCheck at (650) 573-1968 or email at info@biocheckinc.com.